QA: Keenova Therapeutics plc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567892_2022_Keenova_Therapeutics_plc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001567892, Keenova Therapeutics plc

  xvar xval
0 AssetsCurrent 2,309,600,000
1 IntangibleAssetsNetIncludingGoodwill 5,448,400,000
2 PropertyPlantAndEquipmentNet 776,000,000
3 remainder_Assets 382,300,000
4 LiabilitiesCurrent 1,942,200,000
5 LiabilitiesNoncurrent 85,800,000
6 remainder_Liabilities 6,574,900,000
7 CostOfGoodsAndServicesSold 1,317,100,000
8 SellingGeneralAndAdministrativeExpense 581,800,000
9 ResearchAndDevelopmentExpense 205,200,000
10 remainder_Expenses 851,300,000
11 remainder_Revenues 2,208,800,000
12 remainder_NetIncome 29,200,000
13 remainder_ComprehensiveNetIncome 1,300,000
  yvar yval
0 Assets 8,916,300,000
1 Liabilities 8,602,900,000
2 Expenses 2,955,400,000
3 Revenues 2,208,800,000
4 StockholdersEquity 313,400,000
5 NetIncome -717,400,000
6 ComprehensiveNetIncome -716,750,000
7 BaseVar 11,356,950,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.00383
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time